It has been shown previously that CTCF PARylation is reduced in T47D human breast cancer cells that contain an epigenetically silenced p16INK4A tumor suppressor gene and loss of an upstream CTCF-regulated chromatin boundary when compared to MDA-MB-435 (435) breast cancer cells [19]. This evidence concerns the gene CDKN2A and breast cancer.